{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/ACHV",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# ACHIEVE LIFE SCIENCES, INC. (NASDAQ: ACHV) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is ACHIEVE LIFE SCIENCES, INC., listed on NASDAQ under ticker ACHV, with ISIN US0044685008 and LEI 549300V82ZKZDTAU0A46. Its security type is Corporate and its segment is not on the record. Its sector is 2835 In Vitro & In Vivo Diagnostic Substances and its jurisdiction is United States, Delaware. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 71 filings in the twelve months to 2026-11-08, across 35 filing days. The median gap between filing days is 4.0 days, against a NASDAQ median of 6.0 days and a sector median of 6.5 days. The latest filing is dated 2026-10-06 and is of type directors_dealings, 33 days before the record date. The NASDAQ median latency is 5.0 days and the sector median latency is 4 days.\n\n## Auditor\n\nThe auditor of record is PricewaterhouseCoopers LLP, located in Vancouver, Canada. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 11 research houses: Canaccord Genuity LLC, Citizens JMP Securities, H.C.Wainwright & Co, Jones Trading, Maxim Group, Morgan Stanley, Lake Street Capital, LifeSci Capital, Raymond James & Associates, Stifel and Zacks.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.\n\n## Sources\n\n10 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)\n- https://data.sec.gov/submissions/CIK0000949858.json (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/ACHV (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://www.sec.gov/Archives/edgar/data/949858/000119312526120690/achv-20251231.htm (the auditor)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://ir.achievelifesciences.com/stock-data/analyst-coverage (coverage)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/ACHV (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/949858/000119312526120690/achv-20251231.htm",
    "state": "sourced",
    "value": "PricewaterhouseCoopers LLP"
   },
   "auditor_firm_id": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/949858/000119312526120690/achv-20251231.htm",
    "state": "sourced",
    "value": "271"
   },
   "auditor_location": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/949858/000119312526120690/achv-20251231.htm",
    "state": "sourced",
    "value": "Vancouver, Canada"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/ACHV",
  "coverage": {
   "count": 11,
   "houses": [
    {
     "analyst": "Gary Nachman",
     "house": "Canaccord Genuity LLC",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.achievelifesciences.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Jason Butler",
     "house": "Citizens JMP Securities",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.achievelifesciences.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Brandon Folkes",
     "house": "H.C.Wainwright & Co",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.achievelifesciences.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Justin Walsh",
     "house": "Jones Trading",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.achievelifesciences.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Jason McCarthy",
     "house": "Maxim Group",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.achievelifesciences.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Maxwell Skor",
     "house": "Morgan Stanley",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.achievelifesciences.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Thomas Flaten",
     "house": "Lake Street Capital",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.achievelifesciences.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Patrick Dolezal",
     "house": "LifeSci Capital",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.achievelifesciences.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Ryan Deschner",
     "house": "Raymond James & Associates",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.achievelifesciences.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "James Condulis",
     "house": "Stifel",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.achievelifesciences.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "John Vandermosten",
     "house": "Zacks",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.achievelifesciences.com/stock-data/analyst-coverage",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://ir.achievelifesciences.com/stock-data/analyst-coverage",
     "result": "read: 11 of 11 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 19,
     "median_cadence_gap_days": 6.5,
     "median_filings": 61,
     "median_latency_days": 4,
     "name": "2835 In Vitro & In Vivo Diagnostic Substances"
    }
   },
   "by_type": {
    "agm_egm": 3,
    "corporate_news": 2,
    "director_change": 2,
    "directors_dealings": 29,
    "prospectus": 3,
    "regulatory_filing": 25,
    "results": 7
   },
   "cadence_median_gap_days": 4,
   "filing_days": 35,
   "filings": 71,
   "latency_days": 33,
   "latest": [
    {
     "category": "4",
     "date": "2026-10-06",
     "source": "https://www.sec.gov/Archives/edgar/data/949858/000195394326000004/xslF345X06/form4-10062026_081008.xml",
     "title": "4",
     "type": "directors_dealings"
    },
    {
     "category": "3",
     "date": "2026-10-06",
     "source": "https://www.sec.gov/Archives/edgar/data/949858/000195394326000002/xslF345X06/form3-10062026_081053.xml",
     "title": "3",
     "type": "directors_dealings"
    },
    {
     "category": "8-K",
     "date": "2026-10-01",
     "source": "https://www.sec.gov/Archives/edgar/data/949858/000119312526410781/achv-20261001.htm",
     "title": "8-K — 8-K (items 5.02)",
     "type": "director_change"
    },
    {
     "category": "4",
     "date": "2026-08-21",
     "source": "https://www.sec.gov/Archives/edgar/data/949858/000119312526361182/xslF345X06/ownership.xml",
     "title": "4 — 4",
     "type": "directors_dealings"
    },
    {
     "category": "144",
     "date": "2026-08-19",
     "source": "https://www.sec.gov/Archives/edgar/data/949858/000194984626000528/xsl144X01/primary_doc.xml",
     "title": "144",
     "type": "regulatory_filing"
    }
   ],
   "latest_filing_date": "2026-10-06",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/ACHV",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "SEC Fails-to-Deliver data (CUSIP for the symbol) · ISIN = US + CUSIP + ISO 6166 check digit",
    "read_date": "2026-10-14",
    "read_date_basis": "last_seen",
    "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data",
    "state": "sourced",
    "value": "US0044685008"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0000949858.json",
    "state": "sourced",
    "value": "United States — Delaware"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-08",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN US0044685008)",
    "state": "sourced",
    "value": "549300V82ZKZDTAU0A46"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0000949858.json",
    "state": "sourced",
    "value": "ACHIEVE LIFE SCIENCES, INC."
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0000949858.json",
    "state": "sourced",
    "value": "2835 In Vitro & In Vivo Diagnostic Substances"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0000949858.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "ACHV"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:afb4c57967c378b6a24c8ba20f067e369a8ff41ab24d96ec4a9213da7f3aca02",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/ACHV",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:afb4c57967c378b6a24c8ba20f067e369a8ff41ab24d96ec4a9213da7f3aca02",
 "path": "/us/NASDAQ/ACHV",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is ACHIEVE LIFE SCIENCES, INC., listed on NASDAQ under ticker ACHV, with ISIN US0044685008 and LEI 549300V82ZKZDTAU0A46. Its security type is Corporate and its segment is not on the record. Its sector is 2835 In Vitro & In Vivo Diagnostic Substances and its jurisdiction is United States, Delaware. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 71 filings in the twelve months to 2026-11-08, across 35 filing days. The median gap between filing days is 4.0 days, against a NASDAQ median of 6.0 days and a sector median of 6.5 days. The latest filing is dated 2026-10-06 and is of type directors_dealings, 33 days before the record date. The NASDAQ median latency is 5.0 days and the sector median latency is 4 days.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is PricewaterhouseCoopers LLP, located in Vancouver, Canada. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 11 research houses: Canaccord Genuity LLC, Citizens JMP Securities, H.C.Wainwright & Co, Jones Trading, Maxim Group, Morgan Stanley, Lake Street Capital, LifeSci Capital, Raymond James & Associates, Stifel and Zacks.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "10 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0000949858.json"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/ACHV"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the auditor",
   "source": "https://www.sec.gov/Archives/edgar/data/949858/000119312526120690/achv-20251231.htm"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://ir.achievelifesciences.com/stock-data/analyst-coverage"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/ACHV"
  }
 ],
 "title": "ACHIEVE LIFE SCIENCES, INC. (ACHV) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}